Michael Myers - Dec 23, 2024 Form SCHEDULE 13D Schedule Report for Quoin Pharmaceuticals Ltd. (QNRX)

Filing Manager: Myers Michael
Reporting Manager: Michael Myers
Security: Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares)
Symbol: QNRX
Shares outstanding: 9.02M shares
Disclosed Ownership: 623K shares
Ownership: 6.9%
Form type: SCHEDULE 13D
Date filed: 1/2/2025, 05:20 PM
Date of event: Dec 23, 2024
Next filing: Jan 28, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Michael Myers	6.9%	623K	623K	0	/s/ Michael Myers	Dr. Michael Myers	0001959547